Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Mettler-Toledo (MTD)

NYSE: MTD · Diagnostics & Research · Columbus, OH

Our rating: Neutral

Neutral reaffirmed at $1762.28, moderate conviction, November 9, 2026.

Breaks if: Would turn Positive if organic revenue growth exceeds 8% for two consecutive quarters, signaling demand re-acceleration that the current multiple does not yet reflect. Would turn Cautious if net margin retreats below 19% in any two of the next three quarterly filings — a sign that pricing power or cost leverage is cracking, which at 41.9x would not be forgiven quickly by the market.

Key figures

Market value$33.2B
Revenue, last 12 months$4.2B
Net income, last 12 months$934M
Free cash flow, last 12 months$871M
Price to earnings35.5×
Free cash flow yield2.6%
Dividend yield0.0%
Operating marginn/a
Return on equityn/a
Beta to the S&P 5000.98
Volatility, annualized31.9%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.1B6.3%$12.29$281M
June 30, 2026$1.0B4.5%$11.55$283M
March 31, 2026$947M7.2%$8.33$122M
December 31, 2025$1.1B8.1%$13.93$184M
September 30, 2025$1.0B7.9%$10.57$275M
June 30, 2025$983M3.9%$9.76$212M
March 31, 2025$884M−4.6%$7.81$177M
December 31, 2024$1.0B11.8%$11.93$225M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

8 ledger entries and 30 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.